233 related articles for article (PubMed ID: 10096537)
1. The immunosuppressive agent mycophenolate mofetil markedly potentiates the activity of lobucavir [1R(1alpha,2beta,3alpha)]-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine against different herpes viruses.
Neyts J; De Clercq E
Transplantation; 1999 Mar; 67(5):760-4. PubMed ID: 10096537
[TBL] [Abstract][Full Text] [Related]
2. The antiherpesvirus activity of H2G [(R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine] is markedly enhanced by the novel immunosuppressive agent mycophenolate mofetil.
Neyts J; Andrei G; De Clercq E
Antimicrob Agents Chemother; 1998 Dec; 42(12):3285-9. PubMed ID: 9835529
[TBL] [Abstract][Full Text] [Related]
3. The anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)-cycloprop-1'-yl]methyl]guanine is markedly potentiated by the immunosuppressive agent mycophenolate mofetil.
Neyts J; De Clercq E
Antiviral Res; 2001 Feb; 49(2):121-7. PubMed ID: 11248364
[TBL] [Abstract][Full Text] [Related]
4. The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivo.
Neyts J; Andrei G; De Clercq E
Antimicrob Agents Chemother; 1998 Feb; 42(2):216-22. PubMed ID: 9527762
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyurea potentiates the antiherpesvirus activities of purine and pyrimidine nucleoside and nucleoside phosphonate analogs.
Neyts J; De Clercq E
Antimicrob Agents Chemother; 1999 Dec; 43(12):2885-92. PubMed ID: 10582877
[TBL] [Abstract][Full Text] [Related]
6. Ribavirin and mycophenolic acid potentiate the activity of guanine- and diaminopurine-based nucleoside analogues against hepatitis B virus.
Ying C; De Clercq E; Neyts J
Antiviral Res; 2000 Nov; 48(2):117-24. PubMed ID: 11114413
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil strongly potentiates the anti-herpesvirus activity of acyclovir.
Neyts J; De Clercq E
Antiviral Res; 1998 Dec; 40(1-2):53-6. PubMed ID: 9864046
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolic acid, an immunosuppressive agent, inhibits HBV replication in vitro.
Gong ZJ; De Meyer S; Clarysse C; Verslype C; Neyts J; De Clercq E; Yap SH
J Viral Hepat; 1999 May; 6(3):229-36. PubMed ID: 10607235
[TBL] [Abstract][Full Text] [Related]
9. Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase.
Tenney DJ; Yamanaka G; Voss SM; Cianci CW; Tuomari AV; Sheaffer AK; Alam M; Colonno RJ
Antimicrob Agents Chemother; 1997 Dec; 41(12):2680-5. PubMed ID: 9420038
[TBL] [Abstract][Full Text] [Related]
10. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells.
Saijo M; Suzutani T; Yoshida I
Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651
[TBL] [Abstract][Full Text] [Related]
11. Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.
Terry BJ; Mazina KE; Tuomari AV; Haffey ML; Hagen M; Feldman A; Slusarchyk WA; Young MG; Zahler R; Field AK
Antiviral Res; 1988 Dec; 10(4-5):235-51. PubMed ID: 2852486
[TBL] [Abstract][Full Text] [Related]
12. (+-)-(1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)-cyclobutyl] guanine [(+-)-BHCG or SQ 33,054]: a potent and selective inhibitor of herpesviruses.
Field AK; Tuomari AV; McGeever-Rubin B; Terry BJ; Mazina KE; Haffey ML; Hagen ME; Clark JM; Braitman A; Slusarchyk WA
Antiviral Res; 1990 Jan; 13(1):41-52. PubMed ID: 2159261
[TBL] [Abstract][Full Text] [Related]
13. Mode of action of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl) cycloprop-1'-yl]methyl]guanine (A-5021) against herpes simplex virus type 1 and type 2 and varicella-zoster virus.
Ono N; Iwayama S; Suzuki K; Sekiyama T; Nakazawa H; Tsuji T; Okunishi M; Daikoku T; Nishiyama Y
Antimicrob Agents Chemother; 1998 Aug; 42(8):2095-102. PubMed ID: 9687413
[TBL] [Abstract][Full Text] [Related]
14. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).
Allison AC; Eugui EM
Clin Transplant; 1996 Feb; 10(1 Pt 2):77-84. PubMed ID: 8680053
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil inhibits the development of Coxsackie B3-virus-induced myocarditis in mice.
Padalko E; Verbeken E; Matthys P; Aerts JL; De Clercq E; Neyts J
BMC Microbiol; 2003 Dec; 3():25. PubMed ID: 14687413
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo antiherpetic effects of (1R,2R)-1-(5'-methylful-3'-yl)propane-1,2,3-triol.
Sasaki K; Hayashi K; Matsuya Y; Sugimoto K; Lee JB; Kurosaki F; Hayashi T
J Nat Med; 2016 Apr; 70(2):217-24. PubMed ID: 26763002
[TBL] [Abstract][Full Text] [Related]
17. The A167Y mutation converts the herpes simplex virus type 1 thymidine kinase into a guanosine analogue kinase.
Balzarini J; Liekens S; Esnouf R; De Clercq E
Biochemistry; 2002 May; 41(20):6517-24. PubMed ID: 12009916
[TBL] [Abstract][Full Text] [Related]
18. Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication.
Gong Y; Matthews B; Cheung D; Tam T; Gadawski I; Leung D; Holan G; Raff J; Sacks S
Antiviral Res; 2002 Aug; 55(2):319-29. PubMed ID: 12103432
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of herpes simplex virus type 1 DNA polymerase by [1R(1 alpha,2 beta,3 alpha)]-9-[2,3-bis(hydroxymethyl)cyclobutyl] guanine.
Terry BJ; Cianci CW; Hagen ME
Mol Pharmacol; 1991 Oct; 40(4):591-6. PubMed ID: 1656194
[TBL] [Abstract][Full Text] [Related]
20. [Research of suppression of the herpes simplex virus reproduction with drug resistance using a combination 15-Lys-bis-Nt with some antiherpetic drugs].
Andronova VL; Grokhovskiĭ SL; Surovaia AN; Deriabin PG; Gurskiĭ GV; Galegov GA
Vopr Virusol; 2014; 59(1):38-41. PubMed ID: 25065145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
